ADP-ribosylation signalling in health and disease
During this webinar we will hear from the 2022 GlaxoSmithKline Award winner, Dr Ivan Ahel at the Sir William Dunn School of Pathology, University of Oxford, UK.
Dr Ahel is a Senior Wellcome Trust Research Fellow at the University of Oxford. Ivan obtained his MSc in Biology at the University of Zagreb, Croatia in 2000, before undertaking a PhD with thesis work carried out at Yale University in Prof Dieter Söll’s group between 2000 and 2003. In 2004, Ivan joined the Cancer Research UK, London Research Institute as a postdoctoral Fellow in Dr Stephen West’s laboratory investigating novel DNA repair protein factors. He was appointed in 2009 as a Junior Group Leader at the Paterson Institute for Cancer Research in Manchester, before moving to the Sir William Dunn School of Pathology, in 2013. General interest of Ivan’s laboratory centres on the basic cellular mechanisms underlying genome stability and the signalling mediated by the poly(ADP-ribose) polymerase (PARP) family of enzymes. Ivan’s laboratory has been funded by major grants from the Wellcome Trust, Cancer Research UK, Biotechnology and Biological Sciences Research Council and Ovarian Cancer Research Fund Alliance.
Since 2012, Ivan is a member of the EMBO Young Investigator Programme and he is also recipient of the prestigious 2013 Cancer Research UK Future Leaders in Cancer Research Prize. During his Award lecture, Dr Ahel will discuss his latest research in ADP-ribosylation signalling in health and disease.